September 11, 2019
Press Release
Atomwise could receive up to US$1.5 billion to develop first in-class and best in-class small molecules through partnership with China’s leading biopharmaceutical company, Hansoh Pharma.
Tag Archives: Hansoh Pharma
Read Article